Structure |
Chemical Name |
CAS |
MF |
|
N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine |
444731-74-2 |
C13H12ClN5 |
|
Trelagliptin succinate |
1029877-94-8 |
C22H26FN5O6 |
|
TAK-438 |
1260141-27-2 |
C21H20FN3O6S |
|
6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
1016636-76-2 |
C13H13BrClN3O |
|
5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester |
70374-38-8 |
C10H12ClNO6S2 |
|
2,2',7,7'-Tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene |
207739-72-8 |
C81H68N4O8 |
|
ledipasvir interMediate |
1441673-92-2 |
C12H20KNO4 |
|
1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE |
18048-64-1 |
C12H14N2O |
|
(6R,S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN DIHYDROCHLORIDE |
62989-33-7 |
C9H15N5O3 |
|
4-Benzofurancarboxylic Acid |
166599-84-4 |
C9H6O3 |
|
Methyl 5-chloro-3-chlorosulfonyl-2-thiophene carboxylate |
70374-37-7 |
C7H8ClNO4S2 |
|
2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid |
70785-61-4 |
C15H14N2O5 |
|
2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one |
277299-70-4 |
C12H14N2O |
|
3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine |
134002-25-8 |
C18H20N2O |
|
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
477600-70-7 |
C14H22N2 |
|
2'-Bromo-2'-deoxyuridine |
72218-68-9 |
C9H11BrN2O5 |
|
Itraconzole intermediate |
|
|
|
(2R,3R,4R,5R)-4-(Acetyloxy)-2-(5-fluoro-4-formamido-2-oxo-1,2-dihydropyrimidin-1-yl)-5-methyloxolan-3-yl acetate |
|
|
|
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-3,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,3R)- |
2209874-09-7 |
C12H20N2O3 |
|
6-METHYLENEANDROST-4-ENE-3,17-DIONE |
19457-55-7 |
C20H26O2 |
|
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
|
(+)-Camphor Bromide |
10293-06-8 |
C10H15BrO |
|
Perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulfonyl fluoride |
16090-14-5 |
C7F14O4S |
|
7-METHOXY-4-(TRIFLUOROMETHYL)COUMARIN |
575-04-2 |
C11H7F3O3 |
|
Tert-Butyl 4-Vinylphenyl Carbonate |
87188-51-0 |
C13H16O3 |
|
4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol |
40004-29-3 |
C13H17F3N2O |
|
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
446292-08-6 |
C22H19N3O6 |
|
3-Iodo-1H-pyrazole |
4522-35-4 |
C3H3IN2 |
|
1-Azepanyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride |
1219982-46-3 |
C13H21ClN4O |
|
Diisopropyl 3,3-dimethoxycyclobutane-1,1-dicarboxylate |
115118-68-8 |
C14H24O6 |
|
Methyl 5-chloro-6-methylpyrazine-2-carboxylate |
77168-85-5 |
C7H7ClN2O2 |
|
Orlistat pellets |
|
|
|
3-Des(1-ethylpropoxy)-3-(1-Methylpropoxy) OseltaMivir |
1052063-37-2 |
C15H26N2O4 |
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
1334513-02-8 |
C18H17F5NO5P |
|
isopropylideneaMinooxyethanol |
83495-51-6 |
C5H11NO2 |
|
5,6,12,13-tetrabromo-Perylo[3,4-cd:9,10-c'd']dipyran-1,3,8,10-tetrone |
321945-85-1 |
C24H4Br4O6 |
|
(4-bromo-2-fluorophenyl)-(3,4,5-trimethoxyphenyl)methanone |
1016544-26-5 |
C16H14BrFO4 |
|
16,16-DIMETHYL PROSTAGLANDIN E2 |
39746-25-3 |
C22H36O5 |
|
6R,7S-Ceftazidime isomer |
|
|
|
Oseltamivir Fructose Adduct 2 |
|
|
|
Sugammadex sodium Pentabromide intermediate |
|
|
|
(3S,5S,2S,3R)-posaconazole |
|
|
|
tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate |
1350636-75-7 |
C11H21NO3S |
|
Isopropyl creatinine |
|
C7H13N3O |
|
2-(4-NITROPHENYL)BUTYRIC ACID |
7463-53-8 |
C10H11NO4 |
|
Ceftiofur Double Side Chain |
|
|
|
Flomoxef Intermediate F3-01 |
|
|
|
5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo- |
1985668-78-7 |
C27H30N4O2 |
|
2',3'-Dideoxy-2',3'-didehydroinosine |
42867-68-5 |
C10H10N4O3 |
|
Cephalosporin |
11111-12-9 |
C16H21N3O8S |
|
3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-one |
15462-91-6 |
C22H26O6 |
|
potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate |
5991-71-9 |
C16H10ClKN2O3 |
|
hexahydro-1-methyl-3-(3-oxo-1-cyclohexen-1-yl)-2H-azepin-2-one |
71556-70-2 |
C13H19NO2 |
|
alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylphenethyl alcohol |
73404-00-9 |
C26H31NO2 |
|
Bis(4-isopropylphenyl)iodonium chloride |
97671-66-4 |
C18H22ClI |
|
(3S,4R,5R)-Oseltamivir |
|
|
|
4-Benzo[b]thien-2-ylbenzenamine |
54492-95-4 |
C14H11NS |
|
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
|
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
|
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
|
4-Methylcumarin |
607-71-6 |
C10H8O2 |
|
Dabigatran intermediate |
|
|
|
INTERMEDIATES |
1243021-74-0 |
C13H26N2O5 |
|
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
|
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
|
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |
|
Silicone intermediate |
|
|
|
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
|
4-AMINO-CHROMEN-2-ONE |
53348-92-8 |
C9H7NO2 |
|
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
|
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
|
PROSTAGLANDIN A2 |
13345-50-1 |
C20H30O4 |
|
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
|
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
|
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
|
5-Bromo-2-methylbenzoic acid |
79669-49-1 |
C8H7BrO2 |
|
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
|
Coumarin |
15938-72-4 |
C28H22O9 |
|
cytidylyl-(5'->3')-guanosine |
4785-04-0 |
C19H25N8O12P |
|
Prostaglandin F3a |
|
|
|
8-iso Prostaglandin F2a-d4 |
|
|
|
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN |
82747-36-2 |
C10H5F3O4 |
|
455284-06-7 |
455284-06-7 |
|
|
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
|
4-Chlorodehydromethyltestosterone |
2446-23-3 |
C20H27ClO2 |
|
2'-iodo-2'-deoxyuridine |
4753-03-1 |
C9H11IN2O5 |
|
(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane |
110567-22-1 |
C20H22O3 |
|
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine |
209401-69-4 |
C6H12N2O |
|
Propanoic acid, 3-[(1S)-1-[(1S,3aS,4E,7aS)-4-[(2Z)-[(3S,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-2-Methylenecyclohexylidene]ethylidene]octahydro-7a-Methyl-1H-inden-1-yl]ethoxy]-, ethyl este |
413571-27-4 |
C38H68O5Si2 |
|
1-Acetyl-4-(4-hydroxyphenyl)piperazine side chain of Ketoconazole |
67914-99-2 |
C13H18N2O3 |
|
(R)-Levofloxacin |
|
C18H20FN3O4 |
|
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) |
906093-30-9 |
C16H22N4O2 |
|
Ofloxacin EP Impurity C |
95848-94-5 |
C18H21N3O4 |
|
Posaconazole Diastereoisomer 11 |
171228-50-5 |
C37H42F2N8O4 |
|
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
941688-05-7 |
C17H18N6 |
|
Eribulin intermediate |
157322-47-9 |
C21H35IO4 |
|
Azacitidine Impurity 3 |
157771-77-2 |
C8H12N4O5 |
|
Lumacaftor Intermediate |
936727-68-3 |
C17H13ClF2N2O3 |
|
3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene |
54690-63-0 |
C24H35NO3Si |